Adaptive Biotechnologies Corp ($ADPT)
Filing Information
| Accession Number | 0001780664-26-000012 |
|---|---|
| Form Type | 4 |
| Filing Date | Mar 18, 2026 |
| Document | View SEC Filing |
Transactions
9
Total Shares
145,512
Total Value
$1,051,496.70
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
President and COO | Common Stock | โ | Mar 16, 2026 | Exercise/Conversion | 14,722 | $6.55 | $96,429.10 | 522,656 | Direct | โ | View Details | |
President and COO | Common Stock | โ | Mar 16, 2026 | Sale | 19,060 | $13.41 | $255,594.60 | 503,596 | Direct | โ | View Details | |
President and COO | Common Stock | โ | Mar 17, 2026 | Exercise/Conversion | 14,722 | $6.55 | $96,429.10 | 518,318 | Direct | โ | View Details | |
President and COO | Common Stock | โ | Mar 17, 2026 | Sale | 19,060 | $13.40 | $255,404.00 | 499,258 | Direct | โ | View Details | |
President and COO | Common Stock | โ | Mar 18, 2026 | Exercise/Conversion | 14,722 | $6.55 | $96,429.10 | 513,980 | Direct | โ | View Details | |
President and COO | Common Stock | โ | Mar 18, 2026 | Sale | 19,060 | $13.18 | $251,210.80 | 494,920 | Direct | โ | View Details | |
President and COO | Stock Option (right to buy) | Derivative | Mar 16, 2026 | Exercise/Conversion | 14,722 | $0.00 | $0.00 | 48,105 | Direct | โ | View Details | |
President and COO | Stock Option (right to buy) | Derivative | Mar 17, 2026 | Exercise/Conversion | 14,722 | $0.00 | $0.00 | 33,383 | Direct | โ | View Details | |
President and COO | Stock Option (right to buy) | Derivative | Mar 18, 2026 | Exercise/Conversion | 14,722 | $0.00 | $0.00 | 18,661 | Direct | โ | View Details |